BRPI0516489A - produtos da bactéria do ácido lático e da bìfida-bactéria com um alto grau de dispersibilidade - Google Patents

produtos da bactéria do ácido lático e da bìfida-bactéria com um alto grau de dispersibilidade

Info

Publication number
BRPI0516489A
BRPI0516489A BRPI0516489-3A BRPI0516489A BRPI0516489A BR PI0516489 A BRPI0516489 A BR PI0516489A BR PI0516489 A BRPI0516489 A BR PI0516489A BR PI0516489 A BRPI0516489 A BR PI0516489A
Authority
BR
Brazil
Prior art keywords
bacteria
high degree
dispersibility
products
lactic acid
Prior art date
Application number
BRPI0516489-3A
Other languages
English (en)
Inventor
Franco Pirovand
Giorgio Reiner
Original Assignee
Vsl Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vsl Pharmaceuticals Inc filed Critical Vsl Pharmaceuticals Inc
Publication of BRPI0516489A publication Critical patent/BRPI0516489A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/04—Preserving or maintaining viable microorganisms

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nutrition Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Molecular Biology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Fodder In General (AREA)
  • Dairy Products (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)

Abstract

PRODUTOS DA BACTéRIA DO áCIDO LáTICO E DA BìFIDA-BACTéRIA COM UM ALTO GRAU DE DISPERSIBILIDADE. A presente invenção refere-se aos produtos liofilizados das bactérias do ácido lático e da bífida-bactéria, caracterizados pelo alto grau de dispersibilidade graças ao uso de poliálcoois e/ou açúcares como agentes dispersantes. As dispersões líquidas desses produtos liofilizados são caracterizadas por um elevado grau de estabilidade.
BRPI0516489-3A 2004-10-15 2005-09-28 produtos da bactéria do ácido lático e da bìfida-bactéria com um alto grau de dispersibilidade BRPI0516489A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT000505A ITRM20040505A1 (it) 2004-10-15 2004-10-15 Liofilizzati di batteri lattici e bifidobatteri ad alta dispersibilita'.
PCT/EP2005/054859 WO2006040257A1 (en) 2004-10-15 2005-09-28 Lyophilised lactic acid bacteria and bifidobacteria products with a high degree of dispersibility

Publications (1)

Publication Number Publication Date
BRPI0516489A true BRPI0516489A (pt) 2008-09-09

Family

ID=35722407

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0516489-3A BRPI0516489A (pt) 2004-10-15 2005-09-28 produtos da bactéria do ácido lático e da bìfida-bactéria com um alto grau de dispersibilidade

Country Status (15)

Country Link
US (1) US20070292402A1 (pt)
EP (1) EP1799807A1 (pt)
JP (1) JP2008516591A (pt)
KR (1) KR20070074592A (pt)
CN (1) CN101065476A (pt)
AR (1) AR051458A1 (pt)
AU (1) AU2005293585A1 (pt)
BR (1) BRPI0516489A (pt)
CA (1) CA2580421A1 (pt)
EA (1) EA200700870A1 (pt)
IL (1) IL182514A0 (pt)
IT (1) ITRM20040505A1 (pt)
MX (1) MX2007004246A (pt)
TW (1) TW200628609A (pt)
WO (1) WO2006040257A1 (pt)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100868777B1 (ko) * 2007-03-15 2008-11-17 재단법인서울대학교산학협력재단 Ｒｓ３ 유형의 저항 전분에 대해 분해능이 있는비피도박테리움 아도레스센티스를 유효성분으로 함유하는것을 특징으로 하는 식품 조성물
JP5354560B2 (ja) * 2007-04-06 2013-11-27 地方独立行政法人北海道立総合研究機構 発酵乳ペーストおよびその製造方法
FR2930443B1 (fr) 2008-04-29 2010-06-25 Oreal Produit extemporane de soin a base d'un lyophilisat de microorganisme et de tensioactif(s) de hlb superieur ou egal a 12
US9649380B2 (en) 2009-01-12 2017-05-16 Pfizer Italia S.R.L. Compositions comprising probiotic and prebiotic components and mineral salts, with lactoferrin
CA2760248C (en) 2009-04-30 2019-05-28 Actogenix Nv Cryoprotectants for freeze drying of lactic acid bacteria
KR20120107451A (ko) * 2009-06-30 2012-10-02 시에이치알. 한센 에이/에스 발효유 제품 제조 방법
CN102178250A (zh) * 2011-04-06 2011-09-14 黑龙江省轻工科学研究院 一种益生菌群发酵肠的制备方法
CN104095219A (zh) * 2013-04-03 2014-10-15 赵景芳 一种益生菌整肠药剂的制备方法
EP3177154B1 (en) * 2014-08-08 2019-09-25 Société des Produits Nestlé S.A. Myo-inositol and probiotics, and their use to prevent excess body weight in infants
WO2016020495A1 (en) * 2014-08-08 2016-02-11 Nestec S.A. Myo-inositol and one or more probiotic and use thereof
EP3177277B1 (en) * 2014-08-08 2020-03-11 Société des Produits Nestlé S.A. Myo-inositol and probiotics and uses
CN104782911A (zh) * 2015-04-01 2015-07-22 镇江天和生物技术有限公司 一种中药益生菌复合饲料添加剂
NZ737752A (en) * 2015-06-15 2022-02-25 4D Pharma Res Ltd Compositions comprising bacterial strains
JP6961339B2 (ja) * 2015-12-18 2021-11-05 アサヒ飲料株式会社 微生物菌体含有飲料
CN106994134B (zh) * 2016-01-25 2020-08-25 深圳华大生命科学研究院 肠道益生菌在预防和/或治疗糖尿病及其相关疾病中的应用
CN106399192A (zh) * 2016-10-25 2017-02-15 江苏微康生物科技有限公司 一种乳酸菌发酵溶胞产物、制备方法及其应用
CN107365705B (zh) * 2017-07-14 2021-01-12 江苏微康生物科技有限公司 一种油溶性益生菌冻干菌粉的冻干保护剂及其应用
JP7506963B2 (ja) * 2018-08-07 2024-06-27 株式会社ヤクルト本社 乳酸菌用培地
KR102009731B1 (ko) 2019-04-15 2019-08-12 주식회사 쎌바이오텍 단백질 가수분해물을 이용한 단백질-다당류 이중코팅 유산균의 제조방법

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1254210B (it) * 1992-02-10 1995-09-14 Simone Claudio De Composizioni dietetiche e/o farmaceutiche a base di batteri lattici liofilizzati, loro preparazione e impiego
ITMI20020399A1 (it) * 2002-02-28 2003-08-28 Ct Sperimentale Del Latte S P Composizioni dietetiche e/o farmaceutiche per uso umano e/o animale abase di preparati microbici probiotici

Also Published As

Publication number Publication date
WO2006040257A1 (en) 2006-04-20
TW200628609A (en) 2006-08-16
KR20070074592A (ko) 2007-07-12
ITRM20040505A1 (it) 2005-01-15
JP2008516591A (ja) 2008-05-22
AU2005293585A1 (en) 2006-04-20
IL182514A0 (en) 2007-09-20
CA2580421A1 (en) 2006-04-20
MX2007004246A (es) 2007-06-25
US20070292402A1 (en) 2007-12-20
EA200700870A1 (ru) 2007-08-31
CN101065476A (zh) 2007-10-31
EP1799807A1 (en) 2007-06-27
AR051458A1 (es) 2007-01-17

Similar Documents

Publication Publication Date Title
BRPI0516489A (pt) produtos da bactéria do ácido lático e da bìfida-bactéria com um alto grau de dispersibilidade
Van Der Veer et al. Comparative genomics of human Lactobacillus crispatus isolates reveals genes for glycosylation and glycogen degradation: implications for in vivo dominance of the vaginal microbiota
Jeong et al. Antimicrobial and anti-biofilm activities of Lactobacillus kefiranofaciens DD2 against oral pathogens
Nikitkova et al. Taking the starch out of oral biofilm formation: Molecular basis and functional significance of salivary α-amylase binding to oral streptococci
Phukan et al. The adherence of Trichomonas vaginalis to host ectocervical cells is influenced by lactobacilli
BRPI0802049A2 (pt) composiÇço cosmÉtica ou dermatolàgica, usos de pelo menos um meio de cultura celular, processo cosmÉtico para melhorar a homeostase cutÂnea e processo para preparar uma composiÇço cosmÉtica ou dermatolàgica
PH12020550941A1 (en) Methods and compositions to prevent microbial infection
BR112019002941A2 (pt) processo para preparar uma bebida ou componente de bebida, bebida ou componente de bebida, e uso de uma bebida
Ravaioli et al. Various biofilm matrices of the emerging pathogen Staphylococcus lugdunensis: exopolysaccharides, proteins, eDNA and their correlation with biofilm mass
WO2017212345A3 (en) Detecting microbial infection in wounds
WO2009002456A3 (en) Methods and compositions relating to progenitor cells
Li et al. The beneficial effect of exopolysaccharides from Bifidobacterium bifidum WBIN03 on microbial diversity in mouse intestine
NZ582626A (en) Thermostabilization of proteins
Subbaram et al. Isolation, identification, characterization and antibiotic sensitivity profile of pathogenic Legionella pneumophila isolates from different water sources
Jurášková et al. Exopolysaccharide (EPS)-producing Streptococcus thermophilus: functional and probiotic potential
Sadeghifard et al. The incidence of nosocomial toxigenic Clostridium difficile associated diarrhea in Tehran tertiary medical centers
BR112021007811A8 (pt) Suplemento probiótico para a saúde metabólica compreendendo lactobacillus
BRPI0511314A (pt) bactérias lácticas e seu uso na prevenção de diarréia
BR112022026825A2 (pt) Processo para reduzir a atividade de contaminação microbiana em um meio de levedura
Ramos et al. Exopolysaccharide-mediated surface penetration as new virulence trait in Enterococcus faecalis
CN107136313A (zh) 一种微生物饲料
Martin-Loeches et al. A week seems to be weak: tailoring duration of antibiotic treatment in Gram-negative ventilator-associated pneumonia
PT1131080E (pt) Seleccao e utilizacoes de estirpes de bacterias lacticas moduladoras da imunidade nao-especifica
ATE466023T1 (de) Mannose-spezifische adhesinen und deren vervendung
Evans et al. Cefixime–tellurite rhamnose MacConkey agar for isolation of Vero cytotoxin‐producing Escherichia coli serogroup O26 from Scottish cattle and sheep faeces

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]